Positive News SentimentPositive NewsNASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis $14.51 +0.30 (+2.09%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$14.48 -0.03 (-0.19%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Precipio Stock (NASDAQ:PRPO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Precipio alerts:Sign Up Key Stats Today's Range$14.21▼$14.7050-Day Range$8.37▼$16.2052-Week Range$3.90▼$16.89Volume6,911 shsAverage Volume18,734 shsMarket Capitalization$21.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. Read More Precipio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScorePRPO MarketRank™: Precipio scored higher than 23% of companies evaluated by MarketBeat, and ranked 847th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Precipio. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Precipio is -7.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precipio is -7.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecipio has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Precipio's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.67% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 53.57%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecipio does not currently pay a dividend.Dividend GrowthPrecipio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.67% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 53.57%, indicating that investor sentiment is decreasing significantly. News and Social Media3.8 / 5News SentimentN/A News SentimentPrecipio has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Precipio this week, compared to 0 articles on an average week.Search Interest1 people have searched for PRPO on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Precipio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $135,007.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders16.90% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.45% of the stock of Precipio is held by institutions.Read more about Precipio's insider trading history. Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPO Stock News HeadlinesPrecipio amends warrant agreement, to receive $1.2M in cashJuly 13, 2025 | investing.comPrecipio, Inc. Modifies Warrant Structure to Reduce Share Dilution and Secure $1.2 Million Cash InflowJuly 11, 2025 | quiverquant.comQI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 27 at 2:00 AM | Porter & Company (Ad)Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As CashlessJuly 11, 2025 | globenewswire.comPrecipio, Inc. Urges Shareholders to Vote by 11 PM Today for Quorum at Upcoming MeetingJune 16, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comPrecipio, Inc.: Precipio Announces its Q1-2025 Financial ResultsMay 15, 2025 | finanznachrichten.dePrecipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue GrowthMay 14, 2025 | quiverquant.comQSee More Headlines PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed this year? Precipio's stock was trading at $5.54 at the start of the year. Since then, PRPO shares have increased by 161.9% and is now trading at $14.5070. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings results on Wednesday, May, 14th. The biotechnology company reported ($0.59) EPS for the quarter. The biotechnology company had revenue of $4.93 million for the quarter. Precipio had a negative net margin of 15.45% and a negative trailing twelve-month return on equity of 25.87%. Read the conference call transcript. When did Precipio's stock split? Shares of Precipio reverse split on the morning of Friday, September 22nd 2023.The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and GE Aerospace (GE). Company Calendar Last Earnings5/14/2025Today7/27/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRPO CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees60Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4.29 million Net Margins-15.45% Pretax Margin-15.45% Return on Equity-25.87% Return on Assets-17.93% Debt Debt-to-Equity Ratio0.03 Current Ratio0.76 Quick Ratio0.57 Sales & Book Value Annual Sales$20.03 million Price / Sales1.10 Cash FlowN/A Price / Cash FlowN/A Book Value$8.16 per share Price / Book1.78Miscellaneous Outstanding Shares1,512,000Free Float1,256,000Market Cap$21.93 million OptionableNo Data Beta1.28 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:PRPO) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.